Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses

Valérie Gounant, Valentine Marie Ferré, Ghassen Soussi, Charlotte Charpentier, Héloïse Flament, Nadhira Fidouh, Gilles Collin, Céline Namour, Sandra Assoun, Alexandra Bizot, Zohra Brouk, Eric Vicaut, Luis Teixeira, Diane Descamps, View ORCID ProfileGérard Zalcman
doi: https://doi.org/10.1101/2021.08.12.21261806
Valérie Gounant
1Université de Paris, North-Paris Cancer University Institute, Thoracic Oncology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
2INSERM Centre d’Investigation Clinique 1425, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
MD, MSc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentine Marie Ferré
3Université de Paris, Virology Department, INSERM UMR1137 “Infection, Antimicrobials, Modelling, Evolution”, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
PharmD, MSc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ghassen Soussi
1Université de Paris, North-Paris Cancer University Institute, Thoracic Oncology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
2INSERM Centre d’Investigation Clinique 1425, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Charpentier
3Université de Paris, Virology Department, INSERM UMR1137 “Infection, Antimicrobials, Modelling, Evolution”, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
PharmD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Héloïse Flament
4Université de Paris, Hematology and Immunology Department, INSERM-U1149, Research Center on Inflammation (CRI) Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
PharmD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadhira Fidouh
3Université de Paris, Virology Department, INSERM UMR1137 “Infection, Antimicrobials, Modelling, Evolution”, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Collin
3Université de Paris, Virology Department, INSERM UMR1137 “Infection, Antimicrobials, Modelling, Evolution”, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
Msc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Céline Namour
1Université de Paris, North-Paris Cancer University Institute, Thoracic Oncology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
2INSERM Centre d’Investigation Clinique 1425, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
MSc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Assoun
1Université de Paris, North-Paris Cancer University Institute, Thoracic Oncology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
2INSERM Centre d’Investigation Clinique 1425, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
MD, Msc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Bizot
1Université de Paris, North-Paris Cancer University Institute, Thoracic Oncology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
2INSERM Centre d’Investigation Clinique 1425, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
MD, MSc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zohra Brouk
1Université de Paris, North-Paris Cancer University Institute, Thoracic Oncology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
2INSERM Centre d’Investigation Clinique 1425, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Vicaut
5Université de Paris, Biostatistics and Clinical Research Department, Lariboisière Hospital (AP-HP.Nord), 2 rue Amboise Paré, 75018 Paris, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis Teixeira
6Université de Paris, North-Paris Cancer University Institute, Breast Diseases Centre, INSERM U976, HIPI, “Pathophysiology of Breast Cancer Team”, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 1 avenue Claude Vellefaux, 75010 Paris, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Descamps
3Université de Paris, Virology Department, INSERM UMR1137 “Infection, Antimicrobials, Modelling, Evolution”, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gérard Zalcman
1Université de Paris, North-Paris Cancer University Institute, Thoracic Oncology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
2INSERM Centre d’Investigation Clinique 1425, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP.Nord), 46 rue Henri Huchard, Paris, France
7INSERM U830 “Cancer, Heterogeneity Plasticity”, Curie Institute Research Centre, 26 rue d’Ulm, 75231 Paris cedex 05, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gérard Zalcman
  • For correspondence: gerard.zalcman@aphp.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

All the data are available on request to the senior authoor of the article, Prof. Gerard ZALCMAN gerard.zalcman{at}aphp.fr

Back to top
PreviousNext
Posted August 13, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses
Valérie Gounant, Valentine Marie Ferré, Ghassen Soussi, Charlotte Charpentier, Héloïse Flament, Nadhira Fidouh, Gilles Collin, Céline Namour, Sandra Assoun, Alexandra Bizot, Zohra Brouk, Eric Vicaut, Luis Teixeira, Diane Descamps, Gérard Zalcman
medRxiv 2021.08.12.21261806; doi: https://doi.org/10.1101/2021.08.12.21261806
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses
Valérie Gounant, Valentine Marie Ferré, Ghassen Soussi, Charlotte Charpentier, Héloïse Flament, Nadhira Fidouh, Gilles Collin, Céline Namour, Sandra Assoun, Alexandra Bizot, Zohra Brouk, Eric Vicaut, Luis Teixeira, Diane Descamps, Gérard Zalcman
medRxiv 2021.08.12.21261806; doi: https://doi.org/10.1101/2021.08.12.21261806

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (685)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (323)
  • Neurology (2786)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)